Hackensack, New Jersey Clinical Trials

A listing of Hackensack, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 193 clinical trials
Featured trial
AutoRun1219

AutomationRun1219

AutoSite1219
 (8.6 away) Contact site
  • 0 views
  • 08 May, 2023
  • +8 other locations
Featured trial
AutoRun1220

AutomationRun1220

AutoSite1220
 (8.6 away) Contact site
  • 0 views
  • 08 May, 2023
  • 1 location
Featured trial
AutoRun1223  

AutomationRun1223

AutoSite1223
 (8.6 away)
  • 0 views
  • 17 May, 2023
  • +8 other locations
Featured trial
AutoRun122490  

AutomationRun122490

AutoSite122490
 (8.6 away)
  • 0 views
  • 17 May, 2023
  • +8 other locations
Featured trial
Study of Lademirsen (SAR339375) in Patients With Alport Syndrome (HERA)

Primary Objectives: To assess the efficacy of lademirsen (SAR339375) in reducing the decline in renal function To assess the safety and tolerability of lademirsen (SAR339375) in subjects with Alport syndrome Secondary Objectives: To assess plasma pharmacokinetic (PK) parameters of the parent compound and its metabolites To assess the potential formation …

Columbia University Medical Center_Investigational Site Number :8400004
 (6.4 away) Contact site
  • 0 views
  • 23 Nov, 2021
  • +22 other locations
Featured trial
Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI  

The objective of the proposed work is to determine whether administration for 12 months of romosozumab followed by 12 months of denosumab will maintain bone mass at the knee in subjects with subacute SCI compared to 24 months of denosumab administration alone.

James J. Peters VA Medical Center
 (8.1 away)
  • 0 views
  • 14 Mar, 2022
  • +1 other locations
Featured trial
Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis (EQUALISE)

This is a multi-center study to evaluate the safety, tolerability, PK, PD, and clinical activity of itolizumab (EQ001) in subjects with Systemic Lupus Erythematosus with or without Active Proliferative Lupus Nephritis

Columbia University Medical Center, Div of Nephrology
 (6.4 away) Contact site
  • 0 views
  • 01 Dec, 2021
  • +16 other locations
Featured trial
AutoRun01464

AutomationRun01464

AutoSite01464
 (8.6 away) Contact site
  • 0 views
  • 21 Dec, 2022
  • 1 location
Featured trial
AutoRun01465

AutomationRun01465

AutoSite01465
 (8.6 away) Contact site
  • 0 views
  • 21 Dec, 2022
  • 1 location
Featured trial
AutoRun014788

AutomationRun014788

AutoSite014788
 (8.6 away) Contact site
  • 0 views
  • 23 Dec, 2022
  • 1 location